CAS 95510-70-6
:Omeprazole sodium
Description:
Omeprazole sodium is a proton pump inhibitor (PPI) primarily used to treat conditions such as gastroesophageal reflux disease (GERD) and peptic ulcers by reducing gastric acid secretion. It is a sodium salt form of omeprazole, which is a substituted benzimidazole. The compound is typically characterized by its white to off-white crystalline powder appearance and is soluble in water, making it suitable for oral formulations. Omeprazole sodium works by irreversibly inhibiting the H+/K+ ATPase enzyme in the gastric parietal cells, leading to decreased acid production. Its pharmacokinetics involve rapid absorption, with peak plasma concentrations occurring within a few hours after administration. The drug is metabolized primarily in the liver and has a relatively short half-life, necessitating once-daily dosing for effective acid suppression. Common side effects may include headache, nausea, and gastrointestinal disturbances. As with other PPIs, long-term use may be associated with certain risks, such as vitamin B12 deficiency and increased susceptibility to gastrointestinal infections.
Formula:C17H19N3O3S·Na
InChI:InChI=1S/C17H19N3O3S.Na/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17;/h5-8H,9H2,1-4H3,(H,19,20);
InChI key:InChIKey=HVAJOLFRLWQQQL-UHFFFAOYSA-N
SMILES:S(CC1=C(C)C(OC)=C(C)C=N1)(=O)C=2NC=3C(N2)=CC=C(OC)C3.[Na]
Synonyms:- 1H-Benzimidazole, 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-, sodium salt
- 1H-Benzimidazole, 6-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-, sodium salt (1:1)
- 5-Methoxy-2-(((4-Methoxy-3,5-Dimethyl-2-Pyridinyl)Methyl)Sulfinyl)-1H-Benzimidazole Sodium Salt
- 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole sodium salt
- 5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl]-1H-benzimidazole sodium salt
- H 168/68 sodium
- Losec Sodium
- Omeprazole Sodium
- Omeprazole powder/pellets/sodium
- Omeprazole, sodium salt
- Sodium omeprazole
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 9 products.
5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole sodium salt
CAS:Formula:C17H19N3NaO3SPurity:%Color and Shape:SolidMolecular weight:368.4058Omeprazole sodium salt
CAS:Formula:C17H19N3NaO3SPurity:≥ 98.0%Color and Shape:White powderMolecular weight:368.41Omeprazole sodium salt hydrate
CAS:<p>Proton pump inhibitor; irreversible blocker of P-type H+/K+ ATPase</p>Formula:C17H18N3O3S•Na•xH2OPurity:Min. 95%Color and Shape:PowderMolecular weight:367.41 g/molOmeprazole sodium salt monohydrate - Bio-X ™
CAS:<p>Omeprazole is a proton pump inhibitor (PPI) that inhibits the production of gastric acid in the stomach. This is due to Omeprazole binding through a stable disulphide bond to the H+/K+ ATPase enzyme found on parietal cells, and preventing hydrogen ion transport. Consequently, gastric acid secretion is supressed. As a PPI, Omerprazole can be used to treat disorders where gastric acid is over-secreted. Examples of these disorders are gastroesophageal reflux disease (GERD) and peptic ulcer disease.</p>Formula:C17H18N3O3S·Na·H2OPurity:Min. 95%Color and Shape:PowderMolecular weight:386.41 g/molOmeprazole Sodium Salt
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Omeprazole Sodium Salt is the salt analogue of Omeprazole (O635000), which binds covalently to proton pump. It inhibits gastric secretion. Used as an anttiulcerative.<br>References Muller, P., et al.: Arzneimittel-Forsch., 33, 1685 (1983); Wallmark, B., et al.: Biochim. Biophys. Acta., 778, 549 (1984); Morii, M., et al.: J. Biol. chem., 268, 21553 (1993); Ritter, M., et al.: Br. J. Pharmacol., 124, 627 (1998)<br></p>Formula:C17H18N3O3S·Na·H2OColor and Shape:Off-WhiteMolecular weight:385.41Omeprazole Sodium
CAS:<p>Omeprazole Sodium is a proton pump inhibitor(PPI) and suppresses gastric acid secretion.</p>Formula:C17H18N3NaO3SPurity:99.84%Color and Shape:Clear In WaterMolecular weight:367.4







